Philip Ashton-Rickardt
Company: AZTherapies
Job title: Senior Vice President, Immunology
Seminars:
Live Speaker Q&A 11:05 am
day: Day One
Small Molecule & Cell Therapies for Neurodegenerative Diseases 10:15 am
• Anti-inflammatory small molecules can dampen the pathogenic activation of microglia • These anti-inflammatories are under evaluation in clinical trials on Alzheimer’s disease and Amyotrophic lateral sclerosis patients • Engineered T cell therapies have the potential to dampen neuroinflammation and promote neuro-regenerationRead more
day: Day One